These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28625271)

  • 41. Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis.
    Rudick CP; Cornell DL; Agrawal DK
    Expert Rev Clin Immunol; 2017 Sep; 13(9):907-919. PubMed ID: 28742984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis.
    Ayala A; Chaudry IH
    Shock; 1996; 6 Suppl 1():S27-38. PubMed ID: 8828095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis.
    Wang F; Huang X; Chung CS; Chen Y; Hutchins NA; Ayala A
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G237-45. PubMed ID: 27288425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathogenesis of sepsis-induced myocardial dysfunction].
    Lou Y; Lin Z
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):374-376. PubMed ID: 29664003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy.
    Monneret G; Venet F
    Cytometry B Clin Cytom; 2016 Jul; 90(4):376-86. PubMed ID: 26130241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-infectious immune suppression: a new paradigm of severe infections.
    Grimaldi D; Llitjos JF; Pène F
    Med Mal Infect; 2014 Oct; 44(10):455-63. PubMed ID: 25169939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The immune system's role in sepsis progression, resolution, and long-term outcome.
    Delano MJ; Ward PA
    Immunol Rev; 2016 Nov; 274(1):330-353. PubMed ID: 27782333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis.
    Gao YL; Zhai JH; Chai YF
    Mediators Inflamm; 2018; 2018():5823823. PubMed ID: 29706799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What is next in sepsis: current trials in sepsis.
    Artigas A; Niederman MS; Torres A; Carlet J
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):859-62. PubMed ID: 23030324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The growing spectrum of anti-inflammatory interleukins and their potential roles in the development of sepsis.
    Zhao HQ; Li WM; Lu ZQ; Sheng ZY; Yao YM
    J Interferon Cytokine Res; 2015 Apr; 35(4):242-51. PubMed ID: 25517926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sepsis in Emergency Medicine].
    Christ M; Geier F; Bertsch T; Singler K
    Dtsch Med Wochenschr; 2016 Jul; 141(15):1074-81. PubMed ID: 27464279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sepsis: pathophysiology and clinical management.
    Gotts JE; Matthay MA
    BMJ; 2016 May; 353():i1585. PubMed ID: 27217054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sepsis Resuscitation: Consensus and Controversies.
    Montanaro N
    Crit Care Nurs Q; 2016; 39(1):58-63. PubMed ID: 26633160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Patients with sepsis].
    Oppert M
    Med Klin Intensivmed Notfmed; 2016 May; 111(4):290-4. PubMed ID: 27160262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mycophenolate Mofetil Protects Septic Mice via the Dual Inhibition of Inflammatory Cytokines and PD-1.
    Huang SW; Chen H; Lu ML; Wang JL; Xie RL; Zhao B; Chen Y; Xu ZW; Fei J; Mao EQ; Chen EZ
    Inflammation; 2018 Jun; 41(3):1008-1020. PubMed ID: 29455288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sepsis : particularities in the elderly patients].
    Roux X; Huttner B; Pugin J; Prendki V; Reny JL
    Rev Med Suisse; 2016 Nov; 12(538):1917-1921. PubMed ID: 28696597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.